Sat Kartar Life Limited (NSE:SATKARTAR)

India · Delayed Price · Currency is INR

140.05

-3.40 (-2.37%)

At close: Jul 7, 2026

-21.45% (1Y)

Market Cap	2.21B -36.5%
Revenue (ttm)	2.01B +141.9%
Net Income	171.02M +582.4%
EPS	10.86 +385.4%
Shares Out	15.74M
PE Ratio	12.90
Forward PE	n/a
Dividend	0.70 (0.49%)
Ex-Dividend Date	n/a

Volume	19,200
Open	138.50
Previous Close	143.45
Day's Range	138.50 - 143.00
52-Week Range	124.00 - 219.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 30, 2026

About Sat Kartar Life

Sat Kartar Life Limited, an ayurvedic healthcare company, provides ayurvedic products in India. The company offers ayurvedic products, vitamins, supplements, and herbal products for various health conditions, including piles, diabetes, sexual health, stamina booster, immunity booster, infertility, joint pain, hair care, addiction care, and respiratory health solutions. It also sells its products through online. The company was formerly known as Sat Kartar Shopping Limited and change its name to Sat Kartar Life Limited in February 2026. The comp... [Read more]

Industry Pharmaceutical Preparations

Founded 2012

Employees 922

Stock Exchange National Stock Exchange of India

Ticker Symbol SATKARTAR

Full Company Profile

Financial Performance

In fiscal year 2026, Sat Kartar Life's revenue was 2.01 billion, an increase of 23.19% compared to the previous year's 1.63 billion. Earnings were 171.02 million, an increase of 74.24%.

Financial Statements